The objective of this study is to evaluate the efficacy of FST-100 (PVP-I 0.4% and dexamethasone 0.1%) Ophthalmic Suspension in the treatment of suspected acute adenoviral conjunctivitis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
30
FST-100 (PVP-I 0.4% and dexamethasone 0.1%). A regimen of 2 drops 4 times a day while awake for 5 days.
A regimen of 2 drops 4 times a day while awake for 5 days.
Wolstan and Goldberg Eye Associates
Torrance, California, United States
Colorado Eye Associates
Colorado Springs, Colorado, United States
Eye Center
Hamden, Connecticut, United States
Clinical cure is defined as a reduction of conjunctival injection and discharge scaled scored each to 0/3.
Time frame: 1 year
Reduction in viral titer by qPCR. Eradication of infectious virus determined by CC-IFA.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The Center for Excellence in Eye
Miami, Florida, United States
Ocean Ophthalmology
North Miami Beach, Florida, United States
The Midwest Center for Sight
Des Plaines, Illinois, United States
Unnamed facility
Hoffman Estates, Illinois, United States
Silverstein Eye Centers
Kansas City, Missouri, United States
St. Johns Clinic
Springfield, Missouri, United States
Ophthalmic Consultants PC The New York Eye and Ear Infirmary
New York, New York, United States
...and 3 more locations